IGF Binding Protein-3 (IGFBP-3), the major IGF carrier in the blood, undergoes limited proteolysis which reduces its affinity for IGFs, thus facilitating dissociation. The functional effects of this at the cellular level were studied by comparing two serum pools, one from healthy adults, one from women during late pregnancy when IGFBP-3 proteolysis is increased. Sera were mixed to yield identical IGF-I and IGF-II concentrations in the two pools. Western ligand and immunoblotting gave the characteristic IGFBP patterns for the two types of serum. Both pools dose-dependently stimulated DNA synthesis in cultured chick embryo fibroblasts. Stimulation by pregnancy serum was twice that by normal serum at 0.05-0.2% concentrations (P < 0.001). In the presence of excess monoclonal anti-IGF-I and -II antibodies, stimulation by both (0.1-0.2%) pools was 70-80% reduced and residual stimulation was similar. Addition of recombinant human (rh)IGFBP-3 dose-dependently depressed both pools' activity, more so for normal serum at 25 and 50 ng/ml, equally for each at 100 ng/ml. At the latter concentration, slight proteolysis of the rhIGFBP-3 was detectable in the presence of 0.2% pregnancy serum, but at 25 ng/ml, proteolysis was absent. These results suggest that IGFs are released more readily from pregnancy serum, accounting for the weaker inhibitory effect of low rhIGFBP-3 concentrations. For identical IGF concentrations, pregnancy serum's greater biological activity therefore reflects greater IGF availability to the cells. This study demonstrates the functional consequences at cellular level of serum IGFBP-3 proteolysis, underlining its significance in regulating serum IGF bioavailability. (J. Clin.
Introduction
The insulin-like growth factors, IGF-I and IGF-II, are produced in many tissues, together with their specific, high-affinity binding proteins (IGFBPs).' The liver, however, is the major 1 . Abbreviations used in this paper: CEF, chick embryo fibroblast; IGFBP, IGF binding protein; rh, recombinant human.
source of IGFs and-IGFBPs in44e bloodstream, which means their action is both paracrine/autocrine and endocrine (1, 2) . The six known species ofbinding protein (IGFBP-1-6) modulate, generally by inhibiting, but sometimes by enhancing, the action of the IGFs on their target cells, although the mechanisms involved remain to be elucidated (3, 4) . In the blood, -20% of the IGFs are carried by IGFBPs as -40-kD binary complexes and 80% as 140-kD ternary complexes where IGF-I-or -II-IGFBP complexes are associated with an 85-kD subunit (5) . The binary complexes are capable of crossing the capillary endothelium, but the ternary complexes are not, which markedly increases the half-lives of the IGFs. Thus, the ternary complexes constitute their circulating reserves and regulate their availability to the tissues (6, 7) .
Recent studies have suggested that the IGFs' bioavailability may be enhanced both in the bloodstream and locally as a result of partial proteolysis by serine proteases of certain IGFBPs, particularly IGFBP-3 (8) (9) (10) . IGFBP-3 proteolysis is detectable in the normal state (11, 12) , but is considerably increased during gestation (8, 9) and in some pathological conditions ( 13, 14) when the needs ofcell growth and metabolism are intensified. Nevertheless, no proofhas as yet been provided that serum IGF bioavailability is increased as a direct result of IGFBP-3 proteolysis. This then was the aim of the present work. The model used was chick embryo fibroblasts in culture, which we had previously shown were particularly sensitive to the mitogenic potency of IGFs and the inhibitory action of IGFBPs (15) (16) (17) . Our data show that in serum IGFs are more readily released from proteolysed than from intact IGFBP, rendering the IGFs more available to the cells, a measure ofwhich is their stimulatory effect on DNA synthesis.
Methods

Serum pools
Serum pools were made up from samples taken from six healthy adults (four men, two women) and six women in the last trimester of pregnancy. The sera had been selected on the basis of total concentrations of IGF-I and IGF-II measured after acidic gel filtration and the electrophoretic profiles of IGFBPs analyzed by Western ligand blotting, according to techniques used routinely in our laboratory ( 18, 19) . The sera were mixed in proportions to yield identical concentrations ofIGF in each pool, i.e., 250 ng/ml IGF-I and 1,450 ng/ml IGF-II.
IGF and IGFBP-3 preparations
and IGF-II ofhuman, rat, and mouse origin and has some cross-reactivity with chicken IGF-I and IGF-II. The anti-IGF-II antibody, raised in the mouse with partially purified rat IGF-II, is specific for IGF-II of rat and human origin and has < 10% cross-reactivity with hIGF-I.
Cell culture
Cultures of chick embryo fibroblasts (CEF) were prepared from trypsinized 10-d-old brown Leghorn chick embryos. Cells were grown in modified Eagle's medium supplemented with antibiotics and 5% newborn calf serum in a CO2 incubator at 370C, as previously described (20) .
Assay ofthe stimulatory activity ofhuman serum. Secondary cultures of CEF were seeded in 96-well plates at 2.5 x I05 cells per cm2 in medium with 5% new-born calf serum. After 5 h, the monolayers were washed and then maintained in serum-free medium for 42 h. Thereaf Preliminary assays had shown that at this concentration anti-IGF-I inhibited 100% of the stimulation by 20 ng/ml rhIGF-I and anti-IGF-II inhibited 100% of that by 10 ng/ml rhIGF-II (not shown).
Assay of rhIGFBP-3 activity. Appropriate concentrations of rhIGFBP-3 were pre-incubated at 4°C for 22 h in fresh medium with or without human serum, then added to CEF under the same culture conditions as for the IGF neutralization by antibodies assay.
Preliminary assays had shown that, like native IGFBP-3 (15), rhIGFBP-3 dose-dependently inhibits IGF-induced stimulation. Total inhibition was obtained with 100 ng/ml IGFBP-3 for 15 ng/ml IGF-I or IGF-II, i.e., a molar ratio of 1.77 (not shown).
Preparation ofculture medium samples for Western blotting. Preincubation and culture conditions were the same as above, except that the CEF were seeded in 24-well plates (500 Ml per well). 1 .5-ml samples of medium with or without human serum and/or rhIGFBP-3 were taken at 0 and 24 h (pooled media from three wells) and 1 mM PMSF immediately added before 10-fold concentration by ultrafiltration on Centricon 10 (W. R. Grace & Co., Amicon Division, Danvers, MA) in preparation for SDS-PAGE. Each sample analyzed represented 0.5 ml equivalent of culture medium.
Western ligand-and immunoblotting
Electrophoretic analysis of IGFBPs was performed according to the method developed in our laboratory ( 19). 16 X 18-cm gels with the Protean II xi System (Bio-Rad Laboratories, Richmond, CA) were used for the serum samples, and 6 X 8-cm gels with the Mini-Protean II System for culture medium samples. The smaller gels are more convenient for low-protein samples, even if they yield poorer resolution. Electrophoretic conditions were the same for the two systems. Briefly, after migration on denaturing (SDS) 12.5% polyacrylamide gels under nonreducing conditions, the proteins were electroblotted onto nitrocellulose. IGFBPs were detected, as previously described ( 12 ), by successively incubating the same nitrocellulose sheets with (a) a mixture of '25I-IGF-I and -11(200,000 cpm each), followed by autoradiography, (b) a specific polyclonal anti-hIGFBP-3 antibody raised in the rabbit against rhIGFBP-3 (1:1,000 dilution), and (c) with anti-rabbit IgG antibody coupled to horse radish peroxidase, followed by revelation by chemiluminescence with an ECL detection system (Amersham, Aylesbury, England).
Statistics
The experiments illustrated are representative of three to five separate experiments. t test was used for comparison of means.
Results
Stimulation ofDNA synthesis in chick embryo fibroblasts by pregnancy and normal human sera. Fig. 1 The lower portion of the figure shows the results of electrophoretic analysis of the IGFBPs in the two serum pools. With Western ligand blotting, normal serum had the two major bands corresponding to the 42-39-kD doublet for IGFBP-3 and lower-intensity bands corresponding to IGFBP-2 (34 kD), IGFBP-1 (30 kD), and IGFBP-4 (24 kD) (22) . In pregnancy serum, the 42-39-kD doublet had disappeared, which is characteristic of this physiological condition where IGFBP-3 proteolysis is particularly pronounced (8) . With immunoblotting, the anti-hIGFBP-3 polyclonal antibody revealed in normal serum the 42-39-kD doublet for intact IGFBP-3 and, in addition, material migrating at 30 kD which corresponds to the major proteolytic fragment of IGFBP-3, as seen in the normal state ( 12) . In pregnancy serum, only the 30-kD fragment was detectable, appearing as a broad, dense band, together with a faint band at 20 kD corresponding to a small proteolytic fragment.
Inhibition ofserum-induced stimulation ofDNA synthesis by anti-IGF antibodies. To determine the IGFs' contribution to serum-induced stimulation, a second series of experiments was done comparing stimulation by 0.1 and 0.2% concentrations of the two pools with and without excess anti-IGF-I and -II antibody. Fig. 2 shows that for cells maintained for 24 h in medium pre-incubated with antibody and serum there was a dramatic drop in stimulation ofDNA synthesis. The percentage ofinhibition was the same for normal and pregnancy serum: 72 and 70% with 0.1% serum and 80 and 79% with 0.2% serum. Residual stimulation that could not be suppressed by anti-IGF antibody was slightly, but not significantly, greater with pregnancy than with normal serum.
It could be concluded from these first series of experiments that (a) IGFs are essential for DNA synthesis to occur, and (b) that the difference in potency between the two serum pools, which were matched for IGF-I and IGF-II concentrations, could be accounted for by IGF activity.
Inhibition ofserum-induced stimulation ofDNA synthesis by recombinant hIGFBP-3. By way of confirming that the greater stimulatory potency of pregnancy serum was due to greater bioavailability of IGFs, a third series of experiments was done in which culture media with and without 0.2% normal or pregnancy serum were pre-incubated with increasing concentrations of rhIGFBP-3. In theory, if the IGFs are more readily released in pregnancy serum than in normal serum, there would be differences between the two serum pools in the dose-related inhibition of IGF activity by the added rhIGFBP-3. Fig. 3 A illustrates the dose-dependent inhibitory effect of rhIGFBP-3 on serum-stimulated DNA synthesis. IGFBP-3 alone, added to medium without serum, had no effect. With high concentrations ofIGFBP-3 ( 100 ng/ml), residual stimulation of DNA synthesis was the same for normal and pregnancy serum. With lower concentrations, the inhibitory effect was weaker on pregnancy serum than on normal serum. This is more clearly illustrated in Fig. 3 B where the results are expressed in terms ofpercentage inhibition, showing the dose-response curves for pregnancy and normal serum to be very different. Normal serum was already inhibited by > 30% by 25 ng/ml rhIGFBP-3, whereas pregnancy serum was barely affected. At higher IGFBP-3 concentrations, the inhibition curve for normal serum flattened more than that for pregnancy serum. These results reflect the differences between the two serum pools in IGF availability to the cells. Similar results were obtained when the cells were cultured with serum and IGFBP-3 added to the medium at 0 h without pre-incubation (not shown).
At this point it was necessary to establish whether the weaker inhibition by pregnancy serum in the presence of 50 ng/ml and especially 25 ng/ml rhIGFBP-3 was indeed due to more extensive dissociation of the IGFs bound to proteolysed serum IGFBP-3, rather than degradation by pregnancy-associated proteases ofthe rhIGFBP-3 which would then become a less effective inhibitor. The culture media at the beginning (0 h) and end (24 h) of the experiment were therefore compared by Western ligand and immunoblotting. These results are shown in Fig. 3 C. At 0 h, ligand blotting revealed in the media containing added nonglycosylated rhIGFBP-3 a band at 32 kD which corresponds to this IGFBP. The 42-39-kD doublet for native (glycosylated) IGFBP-3 in normal serum was at the limit of detectability ( 1Al equivalent of serum applied to the gel, as opposed to the 4 sl represented in Fig. 1 ). With immunoblotting, which is more sensitive than ligand blotting, the antihIGFBP-3 antibody clearly revealed both the 42-39-kD doublet for intact native IGFBP-3 and the 30-kD proteolytic fragment, the latter being the only one visible in the medium to which pregnancy serum had been added. The 32-kD band for nonglycosylated rhIGFBP-3 appeared just above the fragment.
At 24 h the electrophoretic profiles for the different experimental conditions were essentially the same as those at 0 h, with, in addition, (a) a 32-kD band appearing in the conditioned media with ligand blotting, but not with immunoblotting, which corresponds to the major IGFBP secreted by chick embryo fibroblasts (and which, by its migration compared with that in human and other mammalian sera, may be IGFBP-2) and (b) bands corresponding to proteins of 20 kD and less that were detectable by the anti-hIGFBP-3 antibody in the media to which 50 ng/ml and especially 100 ng/ml rhIGFBP-3 had been added, but only in the presence of serum (particularly pregnancy serum), indicating slight and dose-dependent degradation of rhIGFBP-3 by serum proteases. More importantly, there was no degradation with 25 ng/ml rhIGFBP-3, which 2288 Blat, Villaudy, and Binoux meant that the weaker inhibition by pregnancy serum at that concentration was attributable to more extensive IGF release from pregnancy than from normal serum and lesser sequestration by rhIGFBP-3.
Discussion
This study clearly shows that, at the serum concentrations used and for equal concentrations of IGF-I and IGF-II, pregnancy serum is a more potent stimulator of DNA synthesis in cultured CEFs than is normal serum. This greater potency is dependent on IGFs, since stimulation was suppressed by excess anti-IGF-I and -II antibodies and nonsuppressible residual stimulation was similar in the two types of serum.
In addition, rhIGFBP-3, which dose dependently inhibited serum-induced stimulation by both pools, reduced their biological activities to the same level at a concentration of 100 ng/ml. At lower rhIGFBP-3 concentrations, pregnancy serum was subject to lesser inhibition than normal serum, which, as demonstrated by our experiments, reflects the greater availability to their target cells of the IGFs in pregnancy serum. This greater bioavailability of IGFs is a direct consequence of the limited proteolysis of IGFBP-3 by serine proteases which exist in the normal state, but whose activity is maximal during pregnancy (8, 12) . This structural alteration of IGFBP-3 results in a loss of affinity for IGFs, which accounts for its poor detectability or lack thereof in ligand blotting (8) . As seen in Fig. 1 , the 42-39-kD doublet for intact IGFBP-3 disappears in pregnancy serum and is replaced by a 30-kD form detectable by immunoblotting and corresponding to the major proteolytic fragment of IGFBP-3. Serum IGFBP-3 concentrations assayed by RIA have been reported to be at least equal to or more often higher in pregnancy serum than in normal serum (23) . Limited proteolysis ofIGFBP-3 does not disrupt the 140-kD complexes with which -80% ofIGFs are associated in normal serum (8, (24) (25) (26) . For this reason, some authors claim that these complexes remain functionally unchanged, particularly since they can be reconstituted from acidified pregnancy serum in the presence of the acid-labile subunit (26) . However, we have shown that the structural alteration of pregnancy serum IGFBP-3, even if slight, does change it functionally in that its reduced affinity for IGFs (especially IGF-I) results in accelerated kinetics ofdissociation of the IGF-IGFBP-3 complexes and redistribution of the IGFs among the circulating pools, with, in particular, increased proportions of free IGF-I (27) . Since the anti-IGF-I mAb used for this study cross-reacts with IGF-II, we were unable to determine whether the increased biological activity of pregnancy serum was attributable to IGF-I and/or IGF-II.
Although our experimental conditions cannot faithfully reflect physiological conditions, since the 140-kD complexes do not (or barely) cross the capillary barrier (6) .00 'MI and other IGFBPs in regulating the bioavailability of locally produced IGFs. This proteolysis therefore constitutes a major mechanism in the autocrine/paracrine control of cell growth and metabolism (10, (28) (29) (30) (31) . Finally, the findings described here neatly fit in with known mechanisms of activation of various growth factors (32, 33) and, more generally, with the role played by proteases in the control of cell proliferation (34, 35).
